Neuraxpharm CEO Confirms Expansion Into New Markets, Including US
Company’s Value-Added Segment Expected To Soon Account For Half Of Sales
In an exclusive interview with Generics Bulletin, Neuraxpharm CEO Jörg-Thomas Dierks reveals that the company plans to expand out of Europe into other markets by acquiring companies in regions such as the US.
